Cure Alveolar Soft Part Sarcoma International (iCureASPS) • U.S. Food and Drug Administration Accepts Bristol-Myers Squibb’s Applications for Opdivo (nivolumab) Four-Week Dosing S

Page 1 of 1

U.S. Food and Drug Administration Accepts Bristol-Myers Squibb’s Applications for Opdivo (nivolumab) Four-Week Dosing S

Posted: Fri Dec 15, 2017 10:35 pm

by D.ap

U.S. Food and Drug Administration Accepts Bristol-Myers Squibb’s Applications for Opdivo (nivolumab) Four-Week Dosing Schedule Across All Approved Indications

https://news.bms.com/press-release/corp ... s-squibbs-